This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Medtronic, Inc., Medtronic Bakken Research Center B.v.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Estelle Fraysse: Innovator in Medical Technology
Introduction
Estelle Fraysse is a prominent inventor based in Eindhoven, Netherlands. She has made significant contributions to the field of medical technology, particularly in the development of innovative devices for cardiovascular applications. With a total of 3 patents, her work has the potential to improve patient outcomes in critical medical procedures.
Latest Patents
Fraysse's latest patents include a delivery catheter system and a prosthetic heart valve. The delivery catheter system features an integrated embolic filter that can be deployed prior to the delivery of a prosthesis in a patient's vasculature. This filter is designed to be retrievable after the prosthesis is delivered, ensuring that it can effectively prevent embolic events during the procedure. The prosthetic heart valve she developed is notable for its deformable design, allowing it to transition between collapsed and target conditions. This valve includes an inner frame and a braided wire mesh, which work together to create a cavity that enhances its functionality.
Career Highlights
Throughout her career, Estelle Fraysse has worked with leading companies in the medical field, including Medtronic, Inc. and Medtronic Bakken Research Center B.V. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in medical devices.
Collaborations
Fraysse has collaborated with notable professionals in her field, including Patrick Kleijnen and Niels Van Der Knaap. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.
Conclusion
Estelle Fraysse is a trailblazer in the medical technology sector, with her inventions poised to make a significant impact on patient care. Her dedication to innovation and collaboration continues to drive advancements in cardiovascular treatments.